T. Christopher

Learn More
BACKGROUND Several clinical studies have demonstrated that levels of adiponectin are significantly reduced in patients with type 2 diabetes and that adiponectin levels are inversely related to the risk of myocardial ischemia. The present study was designed to determine the mechanism by which adiponectin exerts its protective effects against myocardial(More)
BACKGROUND Intracellular proteins involved in oxidative stress and apoptosis are nitrated in diseased tissues but not in normal tissues; definitive evidence to support a causative link between a specific protein that is nitratively modified with tissue injury in a specific disease is limited, however. The aims of the present study were to determine whether(More)
An enormous quantity of personal health information is available in recent decades and tampering of any part of this information imposes a great risk to the health care field. Existing anonymization methods are only apt for single sensitive and low dimensional data to keep up with privacy specifically like generalization and bucketization. In this paper, an(More)
Clinical studies have identified hypoadiponectinemia as an independent hypertension risk factor. It is known that adiponectin (APN) can directly cause vasodilation, but the doses required exceed physiologic levels several fold. In the current study, we determine the effect of physiologically relevant APN concentrations upon vascular tone, and investigate(More)
  • 1